Characterization of the release of cholecystokinin from a murine neuroendocrine tumor cell line, STC-1.
The murine neuroendocrine cell line, STC-1, was found to contain 296.8 +/- 1.8 fmol of cholecystokinin-like immunoreactivity (CCK-LI) per mg cell protein. Immunocytochemical stain of STC-1 cells maintained in monolayer culture indicated that CCK-LI activity was present in 93% of the cells. Analysis by reverse-phase high-performance liquid chromatography indicated that STC-1 cells contained CCK-8 and an unidentified form as the predominant storage form. form. However, only CCK-8 was released into the culture medium upon stimulation by various secretagogues. The release of CCK-LI from STC-1 cells was stimulated by dibutyryl cAMP, forskolin, KCl, A23187, 4 beta-phorbol 12-myristate 13-acetate and luminal stimulants, e.g., sodium oleate, L-tryptophan, camostat and plaunotol. The release of CCK-LI from STC-1 cells was also stimulated by a neuropeptide, bombesin. The stimulatory effects of most of these agents were dose dependent. The stimulatory effects of dibutyryl cAMP, forskolin, and plaunotol were potentiated by 3-isobutyl-1-methyl xanthine, while that of camostat was not. The results obtained in this study indicate that the release of CCK from STC-1 cells shares the same characteristics of CCK release as from the CCK-secreting cells of the intestinal mucosa observed both in the dog and the rat in vitro and in vivo. Thus, the cellular mechanism of CCK release which appears to be cAMP- and Ca(2+)-dependent may be modulated by cellular protein kinase C activity. The STC-1 cell appears to be a suitable model for studying the mechanism of CCK release.
Chang
C H
CH
Department of Medicine, University of Rochester Medical Center, NY 14642.
Chey
W Y
WY
Sun
Q
Q
Leiter
A
A
Chang
T M
TM
D000818:Animals; D001839:Bombesin / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002766:Cholecystokinin / Q000235:genetics / Q000378:metabolism*; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D004224:Diterpenes; D004305:Dose-Response Relationship, Drug; D004952:Esters; D005233:Fatty Alcohols / Q000494:pharmacology; D016670:Gabexate / Q000031:analogs & derivatives*; D015870:Gene Expression / Q000187:drug effects; D006146:Guanidines / Q000494:pharmacology; D051379:Mice; D014407:Tumor Cells, Cultured / Q000378:metabolism
D004224:Diterpenes; D004952:Esters; D005233:Fatty Alcohols; D006146:Guanidines; C034532:camostat; D005576:Colforsin; D000001:Calcimycin; D016670:Gabexate; D003994:Bucladesine; D002766:Cholecystokinin; D000242:Cyclic AMP; C047686:plaunotol; D001839:Bombesin